N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
Jaejeong Kim, Changyu Kang, Jin-Wook Yoo, In-Soo Yoon, Yunjin Jung, Wenbing Dai · 2023
Read N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis by Jaejeong Kim, Changyu Kang, Jin-Wook Yoo, In-Soo Yoon, Yunjin Jung, Wenbing Dai (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10675528.txt.
Description
Jaejeong Kim and co-authors report a 2023 drug study in rats with colitis, a swelling of the colon. They made a new form of the drug riluzole that is meant to release the drug in the colon and not spread through the rest of the body. The new form links riluzole to a small acid based part.
In tests, the new form reached the colon, stayed intact in the small gut, and turned into riluzole where it was needed. Rats given the drug by mouth had less colon harm and swelling than rats given an older form. Less drug entered the blood, which points to fewer side effects.
Catalog record
| CREATOR | Jaejeong Kim, Changyu Kang, Jin-Wook Yoo, In-Soo Yoon, Yunjin Jung, Wenbing Dai |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |